881891-82-3 Usage
General Description
2-Chloro-3-fluoro-4-methylpyridine is a chemical compound with the molecular formula C6H5ClFN. It is a halogenated pyridine derivative, consisting of a pyridine ring with chlorine, fluorine, and methyl substituents. 2-CHLORO-3-FLUORO-4-METHYLPYRIDINE is used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. It is also utilized in the manufacturing of other organic compounds and as a building block in chemical reactions. 2-Chloro-3-fluoro-4-methylpyridine is a colorless to pale yellow liquid with a pungent odor, and it should be handled and stored with care due to its potential hazards.
Check Digit Verification of cas no
The CAS Registry Mumber 881891-82-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,1,8,9 and 1 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 881891-82:
(8*8)+(7*8)+(6*1)+(5*8)+(4*9)+(3*1)+(2*8)+(1*2)=223
223 % 10 = 3
So 881891-82-3 is a valid CAS Registry Number.
InChI:InChI=1/C6H5ClFN/c1-4-2-3-9-6(7)5(4)8/h2-3H,1H3
881891-82-3Relevant articles and documents
PYRIDINE DERIVATIVES AND THEIR USE AS MEDICAMENTS FOR TREATING DISEASES RELATED TO MCH RECEPTOR
-
Page/Page column 99, (2010/10/20)
The present invention encompasses novel substituted pyridine compounds of Formula (I), which act as MCH receptor antagonists. These compositions and pharmaceutical compositions thereof are useful in the prophylaxis or treatment of improving memory function, sleeping and arousal, anxiety, depression, mood disorders, seizure, obesity, diabetes, appetite and eating disorders, cardiovascular disease, hypertension, dyslipidemia, myocardial infarction, binge eating disorders including bulimia, anorexia, mental disorders including manic depression, schizophrenia, delirium, dementia, stress, cognitive disorders, attention deficit disorder, substance abuse disorders and dyskinesias including Parkinson's disease, epilepsy, and addiction.
